Grants and Contributions:
Title:
Development of Rapid Diagnostic Tests for Hepatitis C Virus Infections
Agreement Number:
911989
Agreement Value:
$430,475.00
Agreement Date:
Aug 15, 2018 - Mar 20, 2020
Description:
This project will develop a rapid point of care diagnostic test designed to detect hepatitis C virus (HCV) antibody and/or antigen from human blood, plasma and serum.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Richmond, British Columbia, CA V6V 2X7
Reference Number:
172-2018-2019-Q2-911989
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
869859116
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 80 days. The total amended value is 100,930 dollars.
Amendment Date
Jan 2, 2020
Recipient's Legal Name:
BioLytical Laboratories Inc.
Federal Riding Name:
Steveston--Richmond East
Federal Riding Number:
59031
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
334512
Amendments: